Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases

Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases

US Patent 10450365 · Granted Oct 22, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibody-based therapy of transthyretin (TTR) amyloidosis and human-derived anti2025
Human-derived anti-(poly-GA) dipeptide repeat (DPR) antibody2024
Methods and compositions for theranostic nanoparticles2024
Recombinant human antibodies for therapy and prevention of polyomavirus-related 2023
Recombinant human antibodies for therapy and prevention of polyomavirus-related 2023
Recombinant human antibodies for therapy and prevention of polyomavirus-related 2023
Recombinant human antibodies for therapy and prevention of polyomavirus-related 2023
Human-derived anti-huntingtin (HTT) antibodies and uses thereof2022
Human anti-SOD1 antibodies2022
Antibody-based therapy of transthyretin (TTR) amyloidosis and human-derived anti2021
TDP-43 specific binding molecules2021
Methods and compositions for theranostic nanoparticles2021